STOCKHOLDERS’ EQUITY (Details Narrative) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 20, 2025
USD ($)
shares
|
Oct. 13, 2023
USD ($)
$ / shares
shares
|
Oct. 10, 2023
USD ($)
$ / shares
|
Mar. 31, 2025
USD ($)
|
Jun. 30, 2024
USD ($)
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2024
USD ($)
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Feb. 27, 2025
$ / shares
shares
|
Nov. 25, 2024
RM / shares
shares
|
Sep. 19, 2024
RM / shares
shares
|
||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||||||||
| Preferred stock, shares authorized | shares | 200,000,000 | 200,000,000 | ||||||||||||
| Preferred stock, shares issued | shares | 0 | 0 | ||||||||||||
| Preferred stock, shares outstanding | shares | 0 | 0 | ||||||||||||
| Common stock, shares authorized | shares | 46,000,000 | 500,000,000 | 500,000,000 | 46,000,000 | 1,000,000 | 1,000,000 | ||||||||
| Common stock, shares issued | shares | 50,005,381 | 3,989,056 | ||||||||||||
| Common stock, shares outstanding | shares | 50,005,381 | 3,989,056 | ||||||||||||
| Common stock, par value | (per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | RM 0.01 | RM 0.01 | |||||||||
| Cash proceeds | $ | $ 23,000,000 | $ 23,000,000 | ||||||||||||
| Issuance of shares | $ | $ 22,788,968 | |||||||||||||
| Share based compensation | $ | 30,000 | $ 6,667 | ||||||||||||
| Warrant fair value | $ | $ 38,580 | |||||||||||||
| Warrants outstanding | shares | 115,500 | |||||||||||||
| Common Stock [Member] | ||||||||||||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||||||||
| Common stock, par value | $ / shares | $ 0.0001 | |||||||||||||
| Issuance of shares | $ | $ 1,650,000 | 4,600 | ||||||||||||
| Share based compensation | $ | $ 2 | [1] | ||||||||||||
| Share price | $ / shares | $ 4.40 | $ 4.00 | ||||||||||||
| Warrants to purchase shares | shares | 115,500 | |||||||||||||
| Executive Director [Member] | ||||||||||||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||||||||
| Issuance of shares | $ | $ 5,000 | |||||||||||||
| Share based compensation | $ | $ 16,325 | $ 5,143 | ||||||||||||
| ||||||||||||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|